Income Statement Zhuhai Rundu Pharmaceutical Co., Ltd.

Stocks

002923

CNE1000033G8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 14/08/2026			5-day change	1st Jan Change
11.61 ^CNY	-0.43%		+4.22%	-4.44%

22/05	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT
19/05	China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug	MT

03e7de791034bb09307bcc7930.mfStKSVp4qlRuli_Q9xeU9jP1jWtPNxbbDmRq0aaEz4.44SdWEAE1No05TPJNrEBJbuu-2TueZ0fVUyg4DPAIUepp_wYcQKp7yGPKw

Published financial data: ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	118.79Cr	136.32Cr	128.18Cr	117.68Cr	115.83Cr
Other Revenues, Total	19.8L	90.11L	1.01Cr	55.32L	1.81Cr
Total Revenues	118.99Cr	137.22Cr	129.19Cr	118.24Cr	117.64Cr
Cost of Goods Sold, Total	48Cr	64Cr	69Cr	69Cr	76Cr
Gross Profit	71Cr	74Cr	61Cr	49Cr	41Cr
Selling General & Admin Expenses, Total	48Cr	46Cr	39Cr	31Cr	33Cr
Provision for Bad Debts	5L	25.61L	-7L	1L	11.66L
R&D Expenses	8.43Cr	9.23Cr	13Cr	13Cr	9.24Cr
Other Operating Expenses	1.2Cr	1.53Cr	1.55Cr	1.13Cr	1.26Cr
Other Operating Expenses, Total	57Cr	57Cr	53Cr	45Cr	44Cr
Operating Income	14Cr	17Cr	7.23Cr	3.95Cr	-2.66Cr
Interest Expense, Total	-17.72L	-69.66L	-1.61Cr	-1.58Cr	-1.31Cr
Interest And Investment Income	23.31L	14.79L	22.53L	13.34L	16.73L
Net Interest Expenses	6L	-54.87L	-1.39Cr	-1.44Cr	-1.14Cr
Currency Exchange Gains (Loss)	-13.42L	13L	17.58L	28.53L	-4L
Other Non Operating Income (Expenses)	-9L	-5L	-11.21L	-19.43L	-50.79L
EBT, Excl. Unusual Items	14Cr	16Cr	5.91Cr	2.6Cr	-4.35Cr
Restructuring Charges	-	-	-	-	-1.33Cr
Gain (Loss) On Sale Of Investments	-18.02T	-24.99T	-4L	13.48T	-12.07T
Gain (Loss) On Sale Of Assets	-	46.8T	2L	1.8Cr	6L
Asset Writedown	-2L	-3L	-1L	-4L	-1.68Cr
Insurance Settlements	-	-	-	-	-
Other Unusual Items	1.51Cr	1.99Cr	2.73Cr	-10L	1.34Cr
EBT, Incl. Unusual Items	15Cr	18Cr	8.6Cr	4.26Cr	-5.96Cr
Income Tax Expense	1.2Cr	2.55Cr	1.91Cr	27.44L	38.84L
Earnings From Continuing Operations	14Cr	16Cr	6.69Cr	3.99Cr	-6.35Cr
Net Income to Company	14Cr	16Cr	6.69Cr	3.99Cr	-6.35Cr
Net Income - (IS)	14Cr	16Cr	6.69Cr	3.99Cr	-6.35Cr
Net Income to Common Incl Extra Items	14Cr	16Cr	6.69Cr	3.99Cr	-6.35Cr
Net Income to Common Excl. Extra Items	14Cr	16Cr	6.69Cr	3.99Cr	-6.35Cr
Per Share Items
Net EPS - Basic	0.42	0.46	0.2	0.12	-0.19
Basic EPS - Continuing Operations	0.42	0.46	0.2	0.12	-0.19
Basic Weighted Average Shares Outstanding	33Cr	33Cr	33Cr	33Cr	33Cr
Net EPS - Diluted	0.42	0.46	0.2	0.12	-0.19
Diluted EPS - Continuing Operations	0.42	0.46	0.2	0.12	-0.19
Diluted Weighted Average Shares Outstanding	33Cr	33Cr	33Cr	33Cr	33Cr
Normalized Basic EPS	0.26	0.3	0.11	0.05	-0.08
Normalized Diluted EPS	0.26	0.3	0.11	0.05	-0.08
Dividend Per Share	0.22	0.25	0.2	0.15	-
Payout Ratio	59.13	57.68	153.04	212.36	-100.97
Supplemental Items
EBITDA	20Cr	24Cr	18Cr	17Cr	11Cr
EBITA	14Cr	17Cr	7.39Cr	4.12Cr	-2.51Cr
EBIT	14Cr	17Cr	7.23Cr	3.95Cr	-2.66Cr
EBITDAR	20Cr	24Cr	19Cr	18Cr	12Cr
Total Revenues (As Reported)	118.99Cr	137.22Cr	129.19Cr	118.24Cr	117.64Cr
Effective Tax Rate - (Ratio)	7.89	14.07	22.25	6.44	-6.52
Current Domestic Taxes	89.4L	2.71Cr	1.73Cr	30.05L	84.53L
Total Current Taxes	89.4L	2.71Cr	1.73Cr	30.05L	84.53L
Deferred Domestic Taxes	30.31L	-16.15L	18.66L	-3L	-45.69L
Total Deferred Taxes	30.31L	-16.15L	18.66L	-3L	-45.69L
Normalized Net Income	8.55Cr	10Cr	3.69Cr	1.62Cr	-2.72Cr
Interest Capitalized	61.36L	94.97L	-	30.63L	20.36L
Interest on Long-Term Debt	-	-	2L	4L	7L
Non-Cash Pension Expense	-	-	4L	18.78L	1.33Cr
Supplemental Operating Expense Items
Marketing Expenses	-	33Cr	26Cr	19Cr	20Cr
Selling and Marketing Expenses	42Cr	39Cr	31Cr	25Cr	26Cr
General and Administrative Expenses	5.92Cr	7.02Cr	7.79Cr	6.45Cr	7.17Cr
Research And Development Expense From Footnotes	9.21Cr	9.56Cr	13Cr	13Cr	9.41Cr
Net Rental Expense, Total	15.42L	15.62L	45.46L	45.61L	25.17L
Imputed Operating Lease Interest Expense	5L	5L	11.26L	12.81L	6L
Imputed Operating Lease Depreciation	10L	10.17L	34.2L	32.8L	19.26L
Maintenance & Repair Expenses, Total	1.61Cr	56.53L	33.98L	47.63L	26.96L
Stock-Based Comp., G&A Exp. (Total)	-67.03L	-	-	-	-
Total Stock-Based Compensation	-67.03L	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	25Cr	22Cr	21Cr	21Cr	26Cr
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	86.77T	61.78T	52.23T	65.71T	53.63T
Total Cash And Short Term Investments	25Cr	22Cr	21Cr	21Cr	26Cr
Accounts Receivable, Total	16Cr	20Cr	21Cr	21Cr	20Cr
Other Receivables	30.93L	6.14Cr	39.54L	49.21L	26.15L
Total Receivables	16Cr	26Cr	22Cr	22Cr	20Cr
Inventory	34Cr	44Cr	42Cr	44Cr	39Cr
Other Current Assets, Total	5.91Cr	2.06Cr	2.13Cr	1.88Cr	48.33L
Total Current Assets	81Cr	95Cr	87Cr	89Cr	86Cr
Gross Property Plant And Equipment	123.47Cr	155.34Cr	168.13Cr	177.15Cr	177.95Cr
Accumulated Depreciation	-26Cr	-33Cr	-43Cr	-56Cr	-70Cr
Net Property Plant And Equipment	97Cr	122.37Cr	124.96Cr	120.89Cr	108.22Cr
Long-term Investments	5L	5L	5L	-	-
Other Intangibles, Total	6.9Cr	6.76Cr	6.61Cr	6.44Cr	6.3Cr
Deferred Tax Assets Long-Term	86.14L	1.02Cr	1.07Cr	1.04Cr	1.39Cr
Deferred Charges Long-Term	1.33Cr	1.28Cr	1.99Cr	1.37Cr	97.75L
Other Long-Term Assets, Total	3.73Cr	2.52Cr	1.43Cr	1.05Cr	34.25L
Total Assets	190.94Cr	228.63Cr	222.78Cr	219.36Cr	202.86Cr
Liabilities
Accounts Payable, Total	15Cr	21Cr	15Cr	22Cr	14Cr
Accrued Expenses, Total	16Cr	18Cr	12Cr	11Cr	12Cr
Short-term Borrowings	3.3Cr	6.29Cr	6.05Cr	2.5Cr	13Cr
Current Portion of Long-Term Debt	-	2.53Cr	6.88Cr	11Cr	8.67Cr
Current Portion of Leases	25.24L	17.55L	21.09L	22.16L	11.03L
Current Income Taxes Payable	1L	1.15Cr	22.61L	-	-
Unearned Revenue Current, Total	1.43Cr	4.67Cr	1.09Cr	1.25Cr	1.79Cr
Other Current Liabilities	5.61Cr	5.01Cr	3.19Cr	4.26Cr	3.8Cr
Total Current Liabilities	42Cr	59Cr	45Cr	52Cr	54Cr
Long-Term Debt	25Cr	38Cr	43Cr	36Cr	31Cr
Long-Term Leases	10.82L	10L	74.79L	55.61L	17.71L
Unearned Revenue Non Current	12Cr	12Cr	16Cr	15Cr	14Cr
Deferred Tax Liability Non Current	-	-	23.09L	17.28L	7L
Other Non Current Liabilities	35.96L	11.78L	10.72L	18.87L	55.77L
Total Liabilities	80Cr	109.04Cr	104.86Cr	104.15Cr	99Cr
Common Stock, Total	19Cr	24Cr	33Cr	33Cr	33Cr
Additional Paid In Capital	35Cr	28Cr	18Cr	18Cr	18Cr
Retained Earnings	59Cr	68Cr	66Cr	63Cr	52Cr
Treasury Stock	-1.39Cr	-	-	-	-
Comprehensive Income and Other	-	-	-55	380	-756
Total Common Equity	111.22Cr	119.6Cr	117.92Cr	115.21Cr	103.84Cr
Total Equity	111.22Cr	119.6Cr	117.92Cr	115.21Cr	103.84Cr
Total Liabilities And Equity	190.94Cr	228.63Cr	222.78Cr	219.36Cr	202.86Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34Cr	33Cr	33Cr	33Cr	33Cr
ECS Total Common Shares Outstanding	34Cr	33Cr	33Cr	33Cr	33Cr
Book Value / Share	3.29	3.57	3.52	3.44	3.1
Tangible Book Value	104.32Cr	112.84Cr	111.31Cr	108.77Cr	98Cr
Tangible Book Value Per Share	3.09	3.37	3.32	3.25	2.91
Total Debt	29Cr	47Cr	57Cr	50Cr	53Cr
Net Debt	3.62Cr	25Cr	36Cr	29Cr	28Cr
Debt Equivalent Oper. Leases	1.23Cr	1.25Cr	3.64Cr	3.65Cr	2.01Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	6.38Cr	12Cr	11Cr	6.96Cr	6.94Cr
Inventories - Work In Process, Total	11Cr	13Cr	9.42Cr	6.76Cr	5.46Cr
Inventories - Finished Goods, Total	17Cr	23Cr	27Cr	35Cr	34Cr
Buildings, Total	26Cr	40Cr	50Cr	53Cr	54Cr
Machinery, Total	52Cr	85Cr	97Cr	117.31Cr	121.52Cr
Full Time Employees	1.59T	1.89T	1.94T	1.98T	1.66T
Accumulated Allowance for Doubtful Accounts (Supple)	72.57L	86.66L	81.3L	79.41L	90.18L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	14Cr	16Cr	6.69Cr	3.99Cr	-6.35Cr
Depreciation & Amortization - CF	6.22Cr	7.07Cr	11Cr	13Cr	14Cr
Amortization of Goodwill and Intangible Assets - (CF)	15.42L	15.62L	15.63L	16.32L	14.26L
Depreciation & Amortization, Total	6.37Cr	7.22Cr	11Cr	14Cr	14Cr
Amortization of Deferred Charges, Total - (CF)	89.56L	58.48L	46.59L	60.96L	66.2L
(Gain) Loss From Sale Of Asset	-	-46.8T	-2L	-	-6L
(Gain) Loss on Sale of Investments - (CF)	-4L	-1L	4L	-94.57T	-2L
Asset Writedown & Restructuring Costs	2L	3L	1L	4L	1.68Cr
Provision and Write-off of Bad Debts	5L	25.61L	-7L	1L	11.66L
Other Operating Activities, Total	61.71L	3.68Cr	5.94Cr	2.98Cr	5.69Cr
Change In Accounts Receivable	-24Cr	-5.37Cr	-1.19Cr	2.71Cr	-5.58Cr
Change In Inventories	-3.74Cr	-13Cr	2.09Cr	-95.32L	2.63Cr
Change In Accounts Payable	27Cr	4.97Cr	-8.16Cr	-1.9Cr	-2.18Cr
Change In Deferred Taxes	30.31L	-16.15L	18.66L	-3L	-45.69L
Change in Other Net Operating Assets	-67.03L	-	-	-	-
Cash from Operations	21Cr	14Cr	17Cr	21Cr	10Cr
Capital Expenditure	-38Cr	-25Cr	-17Cr	-8.13Cr	-1.8Cr
Sale of Property, Plant, and Equipment	-	70T	-	-	-
Investment in Marketable and Equity Securities, Total	4.44Cr	1L	-	-1	-12
Other Investing Activities, Total	-	-	-	81.1T	2L
Cash from Investing	-33Cr	-25Cr	-17Cr	-8.12Cr	-1.78Cr
Long-Term Debt Issued, Total	29Cr	23Cr	19Cr	5.39Cr	21Cr
Total Debt Issued	29Cr	23Cr	19Cr	5.39Cr	21Cr
Long-Term Debt Repaid, Total	-7.63Cr	-5.77Cr	-9.04Cr	-13Cr	-15Cr
Total Debt Repaid	-7.63Cr	-5.77Cr	-9.04Cr	-13Cr	-15Cr
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-16.57L	-1.39Cr	-	-	-
Common Dividends Paid	-8.26Cr	-8.97Cr	-10Cr	-8.47Cr	-6.41Cr
Common & Preferred Stock Dividends Paid	-8.26Cr	-8.97Cr	-10Cr	-8.47Cr	-6.41Cr
Other Financing Activities, Total	2.97Cr	-	-51.72L	0	-5.42Cr
Cash from Financing	16Cr	7.32Cr	-44.8L	-16Cr	-6Cr
Foreign Exchange Rate Adjustments	-6L	13.72L	4L	24.32L	4L
Net Change in Cash	2.83Cr	-4.2Cr	-59.31L	-2.53Cr	2.7Cr
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	7.67Cr	8.12Cr	4.01Cr	7.73Cr	8.13Cr
Levered Free Cash Flow	-21Cr	-13Cr	-13Cr	13Cr	11Cr
Unlevered Free Cash Flow	-21Cr	-12Cr	-12Cr	14Cr	12Cr
Change In Net Working Capital	-1.81Cr	5.5Cr	11Cr	-4.97Cr	-30.93L
Net Debt Issued / Repaid	21Cr	18Cr	10Cr	-7.3Cr	5.83Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.06	4.95	2	1.12	-0.79
Return on Total Capital	6.91	6.77	2.65	1.45	-1.03
Return On Equity %	13	13.47	5.63	3.42	-5.8
Return on Common Equity	13	13.47	5.63	3.42	-5.8
Margin Analysis
Gross Profit Margin %	59.76	53.63	46.97	41.48	35
SG&A Margin	39.99	33.5	30.38	26.25	28.23
EBITDA Margin %	16.67	17.16	14.18	14.66	9.74
EBITA Margin %	11.77	12.21	5.72	3.48	-2.14
EBIT Margin %	11.64	12.1	5.6	3.34	-2.26
Income From Continuing Operations Margin %	11.75	11.33	5.18	3.37	-5.4
Net Income Margin %	11.75	11.33	5.18	3.37	-5.4
Net Avail. For Common Margin %	11.75	11.33	5.18	3.37	-5.4
Normalized Net Income Margin	7.19	7.35	2.86	1.37	-2.31
Levered Free Cash Flow Margin	-17.4	-9.42	-10.41	10.65	9.36
Unlevered Free Cash Flow Margin	-17.31	-9.1	-9.63	11.48	10.06
Asset Turnover
Asset Turnover	0.7	0.65	0.57	0.53	0.56
Fixed Assets Turnover	1.53	1.25	1.04	0.96	1.03
Receivables Turnover (Average Receivables)	7.46	7.53	6.19	5.53	5.63
Inventory Turnover (Average Inventory)	1.5	1.64	1.6	1.61	1.83
Short Term Liquidity
Current Ratio	1.91	1.6	1.94	1.69	1.6
Quick Ratio	0.98	0.82	0.96	0.81	0.85
Operating Cash Flow to Current Liabilities	0.49	0.23	0.39	0.4	0.19
Days Sales Outstanding (Average Receivables)	48.94	48.5	59	66.17	64.82
Days Outstanding Inventory (Average Inventory)	242.98	222.67	228.13	226.79	199.69
Average Days Payable Outstanding	86.85	90.04	101.6	96.07	93.36
Cash Conversion Cycle (Average Days)	205.07	181.13	185.54	196.9	171.15
Long Term Solvency
Total Debt/Equity	25.77	39.17	48.58	43.45	51.26
Total Debt / Total Capital	20.49	28.14	32.7	30.29	33.89
LT Debt/Equity	22.58	31.64	37.43	31.87	30.01
Long-Term Debt / Total Capital	17.95	22.74	25.19	22.22	19.84
Total Liabilities / Total Assets	41.75	47.69	47.07	47.48	48.81
EBIT / Interest Expense	78.15	23.83	4.49	2.5	-2.03
EBITDA / Interest Expense	114.1	34.2	11.49	11.16	8.89
(EBITDA - Capex) / Interest Expense	-98.36	-1.94	0.66	6.01	7.52
Total Debt / EBITDA	1.42	1.97	3.09	2.84	4.57
Net Debt / EBITDA	0.18	1.04	1.94	1.67	2.37
Total Debt / (EBITDA - Capex)	-1.64	-34.68	53.81	5.28	5.4
Net Debt / (EBITDA - Capex)	-0.21	-18.31	33.71	3.1	2.8
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.01	15.32	-5.86	-8.48	-0.51
Gross Profit, 1 Yr. Growth %	-6.54	3.49	-17.54	-19.18	-16.05
EBITDA, 1 Yr. Growth %	-2.52	18.68	-22.2	-4.93	-33.67
EBITA, 1 Yr. Growth %	-9.58	19.68	-55.92	-43.62	-161.86
EBIT, 1 Yr. Growth %	-9.81	19.88	-56.44	-44.67	-168.1
Earnings From Cont. Operations, 1 Yr. Growth %	2.87	11.24	-56.97	-40.38	-259.14
Net Income, 1 Yr. Growth %	2.87	11.24	-56.97	-40.38	-259.14
Normalized Net Income, 1 Yr. Growth %	-9.44	17.93	-63.39	-55.9	-270.63
Diluted EPS Before Extra, 1 Yr. Growth %	2.71	12.07	-56.52	-40	-258.33
Accounts Receivable, 1 Yr. Growth %	0.9	26.44	4.84	0.61	-7.23
Inventory, 1 Yr. Growth %	11.1	31.39	-5.76	6.39	-10.72
Net Property, Plant and Equip., 1 Yr. Growth %	67.11	25.82	2.12	-3.26	-10.48
Total Assets, 1 Yr. Growth %	26.14	19.74	-2.59	-1.53	-7.52
Tangible Book Value, 1 Yr. Growth %	7.24	8.17	-1.35	-2.28	-10.32
Common Equity, 1 Yr. Growth %	7.12	7.54	-1.41	-2.29	-9.87
Cash From Operations, 1 Yr. Growth %	-17.75	-34.43	27.9	22.3	-50.56
Capital Expenditures, 1 Yr. Growth %	46.64	-33.13	-30.67	-53.45	-77.89
Levered Free Cash Flow, 1 Yr. Growth %	114.42	-37.57	4.06	-193.22	-12.31
Unlevered Free Cash Flow, 1 Yr. Growth %	115.74	-39.35	-0.38	-208.62	-12.65
Dividend Per Share, 1 Yr. Growth %	0	13.74	-20	-25	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-6.46	4.67	4.2	-7.18	-4.58
Gross Profit, 2 Yr. CAGR %	-14.4	-1.65	-7.62	-18.36	-17.63
EBITDA, 2 Yr. CAGR %	20.82	7.56	-3.91	-14.21	-20.7
EBITA, 2 Yr. CAGR %	18.78	4.02	-27.37	-50.45	-41.31
EBIT, 2 Yr. CAGR %	18.69	3.98	-27.74	-51.21	-39.01
Earnings From Cont. Operations, 2 Yr. CAGR %	8.42	6.98	-30.82	-49.35	-2.59
Net Income, 2 Yr. CAGR %	8.42	6.98	-30.82	-49.35	-2.59
Normalized Net Income, 2 Yr. CAGR %	13.69	3.34	-34.29	-59.88	-14.11
Diluted EPS Before Extra, 2 Yr. CAGR %	8.98	6.86	-30.52	-48.92	-2.53
Accounts Receivable, 2 Yr. CAGR %	-8.14	12.95	15.14	2.71	-3.39
Inventory, 2 Yr. CAGR %	18.32	20.82	11.28	0.13	-2.54
Net Property, Plant and Equip., 2 Yr. CAGR %	48.6	45	13.35	-0.61	-6.94
Total Assets, 2 Yr. CAGR %	19.97	22.9	8.01	-2.06	-4.58
Tangible Book Value, 2 Yr. CAGR %	8.25	7.7	3.3	-1.82	-6.39
Common Equity, 2 Yr. CAGR %	8.76	7.33	2.97	-1.85	-6.16
Cash From Operations, 2 Yr. CAGR %	16.66	-26.56	-8.42	25.07	-22.24
Capital Expenditures, 2 Yr. CAGR %	25.24	-0.98	-31.91	-43.19	-67.92
Levered Free Cash Flow, 2 Yr. CAGR %	43.97	15.7	-19.4	-1.31	-9.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	44.49	14.39	-22.27	4.26	-2.71
Dividend Per Share, 2 Yr. CAGR %	0	6.65	-4.61	-22.54	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.46	0.3	1.03	-0.21	-5
Gross Profit, 3 Yr. CAGR %	-3.13	-8.81	-7.26	-11.65	-17.6
EBITDA, 3 Yr. CAGR %	11.51	20.1	-3.45	-4.41	-21.33
EBITA, 3 Yr. CAGR %	7.66	19.08	-21.86	-33.52	-46.87
EBIT, 3 Yr. CAGR %	7.44	19.09	-22.2	-34.16	-45.71
Earnings From Cont. Operations, 3 Yr. CAGR %	9.37	9.35	-21.03	-34.16	-25.82
Net Income, 3 Yr. CAGR %	9.37	9.35	-21.03	-34.16	-25.82
Normalized Net Income, 3 Yr. CAGR %	4.3	15.08	-26.87	-42.53	-35.42
Diluted EPS Before Extra, 3 Yr. CAGR %	8.81	9.71	-21.06	-33.84	-25.53
Accounts Receivable, 3 Yr. CAGR %	7.42	2.18	10.18	10.08	-0.72
Inventory, 3 Yr. CAGR %	25.16	22.53	11.22	9.62	-3.63
Net Property, Plant and Equip., 3 Yr. CAGR %	46.49	40.58	29.01	7.52	-4.01
Total Assets, 3 Yr. CAGR %	18.81	19.89	13.75	4.73	-3.92
Tangible Book Value, 3 Yr. CAGR %	7.12	8.22	4.59	1.4	-4.74
Common Equity, 3 Yr. CAGR %	8.48	8.35	4.33	1.18	-4.6
Cash From Operations, 3 Yr. CAGR %	8.99	-3.73	-11.64	0.85	-8.21
Capital Expenditures, 3 Yr. CAGR %	48.35	1.6	-12.07	-40.02	-58.52
Levered Free Cash Flow, 3 Yr. CAGR %	90.3	8.97	11.68	-15.28	-5.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	94.23	8.18	9.24	-12.97	-1.79
Dividend Per Share, 3 Yr. CAGR %	0	4.38	-3.1	-11.96	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.79	11.98	4.36	-2.76	-1.25
Gross Profit, 5 Yr. CAGR %	11.28	7.88	-4.95	-12.76	-11.56
EBITDA, 5 Yr. CAGR %	12.83	12.5	5.07	4.98	-10.85
EBITA, 5 Yr. CAGR %	9.47	10.74	-8.02	-16.14	-30.48
EBIT, 5 Yr. CAGR %	9.37	10.66	-8.32	-16.66	-29.59
Earnings From Cont. Operations, 5 Yr. CAGR %	9.83	11.39	-8.94	-19.62	-14.12
Net Income, 5 Yr. CAGR %	9.83	11.39	-8.94	-19.62	-14.12
Normalized Net Income, 5 Yr. CAGR %	9.81	11.72	-13.3	-24.5	-22.06
Diluted EPS Before Extra, 5 Yr. CAGR %	3.18	4.65	-9.21	-19.35	-14.12
Accounts Receivable, 5 Yr. CAGR %	13.56	14.67	10.44	2.39	4.54
Inventory, 5 Yr. CAGR %	32.18	29.12	19.41	13.02	5.5
Net Property, Plant and Equip., 5 Yr. CAGR %	30.94	37.56	32.21	22.38	13.21
Total Assets, 5 Yr. CAGR %	25.37	26.49	14.37	10.58	6.03
Tangible Book Value, 5 Yr. CAGR %	22.75	19.37	5.58	4.09	0.05
Common Equity, 5 Yr. CAGR %	22.8	19.59	6.24	4.15	0
Cash From Operations, 5 Yr. CAGR %	16.96	8.54	1.66	6.9	-16.05
Capital Expenditures, 5 Yr. CAGR %	42.59	47.23	8.64	-19.48	-41.25
Levered Free Cash Flow, 5 Yr. CAGR %	85.43	76.87	34.96	4.74	2.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	96.7	96.42	34.66	6.6	4.39
Dividend Per Share, 5 Yr. CAGR %	-	3.19	-1.87	-7.36	-